S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
Free Trial

Pfizer (PFE) Earnings Date, Estimates & Call Transcripts

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free pfe Stock Alerts
$25.97
+0.58 (+2.28%)
(As of 03:27 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 1
Before Market Opens
Confirmed
Actual EPS
(Jan. 30)
$0.10 Beat By $0.29
Consensus EPS
(Jan. 30)
-$0.19
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

PFE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PFE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pfizer Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$0.50$1.02$0.69 
Q2 20243$0.41$0.82$0.55 
Q3 20243$0.57$0.82$0.68 
Q4 20243$0.58$1.06$0.76 
FY 202412$2.06$3.72$2.68 
Q1 20251$0.59$0.59$0.59 
Q2 20251$0.55$0.55$0.55 
Q3 20251$0.75$0.75$0.75 
Q4 20251$0.74$0.74$0.74 
FY 20254$2.63$2.63 $2.63

PFE Earnings Date and Information

Pfizer last issued its quarterly earnings data on January 30th, 2024. The biopharmaceutical company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of ($0.19) by $0.29. The business had revenue of $14.25 billion for the quarter, compared to analyst estimates of $14.37 billion. Its revenue for the quarter was down 41.3% compared to the same quarter last year. Pfizer has generated $0.36 earnings per share over the last year ($0.36 diluted earnings per share) and currently has a price-to-earnings ratio of 71.9. Earnings for Pfizer are expected to grow by 23.66% in the coming year, from $2.24 to $2.77 per share. Pfizer has confirmed that its next quarterly earnings report will be published on Wednesday, May 1st, 2024. Pfizer will be holding an earnings conference call on Wednesday, May 1st at 10:00 AM Eastern. Interested parties can register for or listen to the call..

Pfizer Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Confirmed)		-------  
1/30/2024Q4 2023($0.19)$0.10+$0.29$0.80$14.37 billion$14.25 billion    
10/31/2023Q3 2023($0.32)($0.17)+$0.15$0.08$13.77 billion$13.23 billion    
8/1/2023Q2 2023$0.57$0.67+$0.10$0.93$13.36 billion$12.73 billion    
5/2/2023Q1 2023$1.00$1.23+$0.23$1.49$16.49 billion$18.28 billion    
1/31/2023Q4 2022$1.03$1.14+$0.11$1.41$24.40 billion$24.30 billion    
11/1/2022Q3 2022$1.47$1.78+$0.31$2.05$21.04 billion$22.64 billion
7/28/2022Q2 2022$1.75$2.04+$0.29$2.35$26.20 billion$27.74 billion    
5/3/2022Q1 2022$1.66$1.62($0.04)$1.87$24.73 billion$25.66 billion    
2/8/2022Q4 2021$0.85$1.08+$0.23$1.57$24.20 billion$23.84 billion    
11/2/2021Q3 2021$1.08$1.34+$0.26$1.26$22.82 billion$24.09 billion    
7/28/2021Q2 2021$0.97$1.07+$0.10$1.16$17.54 billion$18.98 billion    
5/4/2021Q1 2021$0.78$0.93+$0.15$1.00$13.41 billion$14.58 billion  

Pfizer Earnings - Frequently Asked Questions

When is Pfizer's earnings date?

Pfizer has confirmed that its next quarterly earnings data will be published on Wednesday, May 1st, 2024. Learn more on PFE's earnings history.

Did Pfizer beat their earnings estimates last quarter?

In the previous quarter, Pfizer (NYSE:PFE) reported $0.10 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.29. Learn more on analysts' earnings estimate vs. PFE's actual earnings.

How can I listen to Pfizer's earnings conference call?

The conference call for Pfizer's latest earnings report can be listened to online. Listen to Conference Call

How can I read Pfizer's conference call transcript?

The conference call transcript for Pfizer's latest earnings report can be read online. Read Transcript

How much revenue does Pfizer generate each year?

Pfizer (NYSE:PFE) has a recorded annual revenue of $58.50 billion.

How much profit does Pfizer generate each year?

Pfizer (NYSE:PFE) has a recorded net income of $2.12 billion. PFE has generated $0.36 earnings per share over the last four quarters.

What is Pfizer's price-to-earnings ratio?

Pfizer (NYSE:PFE) has a trailing price-to-earnings ratio of 71.89 and a forward price-to-earnings ratio of 11.55. The price/earnings-to-growth ratio is 1.15.

What is Pfizer's EPS forecast for next year?

Pfizer's earnings are expected to grow from $2.24 per share to $2.77 per share in the next year, which is a 23.66% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:PFE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends